Arrowhead Pharmaceuticals (NasdaqGS:ARWR) Update / Briefing Transcript

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) Update / Briefing November 18, 2025 01:30 PM ET Speaker2Good afternoon and welcome to the Arrowhead Pharmaceuticals Redemplo FDA Approval Conference Call. At this time, all attendees are in listen-only mode. A question-and-answer session will follow the presentation. As a reminder, this call is being recorded and a replay will be made available on the Arrowhead website following the conclusion of the event. I'd now like to turn the call over to Vince Anzalone, Vice ...